R&D

	HOME	INTERMEDIATE	PRODUCT	R&D	QUALITY	CONTACT US

Feature Products

CAPECITABINE

We are proud to announce that we have developed the synthesis process of Capecitabine successfully.

BIAPENEM & FAROPENEM

Production process for Biapenem and Faropenem have been well developed. We supply the high-quality, cost-effective and constant commercial intermediates also.


Product (API) Name	Specification

Neurology
Atracurium Besylate	BP, USP
Memantine Hydrochloride	In-house Specification
Quetiapine Fumarate	In-house Specification

Carbapenems
Biapenem	In-house Specification
Faropenem	In-house Specification

Antibiotic
Ganciclovir	CP，USP
Moxifloxacin Hydrochloride	In-house Specification
Trifluridine	USP
Valaciclovir	In-house Specification
Valaciclovir Hydrochloride	CP

Oncology & Relatives
Calcium Folinate	CP, USP, EP, BP
Capecitabine	In-house Specification
Etoposide	BP, USP
Folinic Acid	In-house Specification
Imatinib Mesylate	In-house specification
Irinotecan	In-house specification
Mesna	In-house specification, EP, CP
Methotrexate	USP, EP, CP
Methotrexate Disodium	In-house specification
Temozolomide	In-house specification

* Patent restraints in certain countries restrict the availability of selected products listed above.